| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 04/10/2003 | WO2002100348A8 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 04/10/2003 | WO2002046406A3 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 04/10/2003 | WO2002040666A3 Fat regulated genes, uses thereof, and compounds for modulating same |
| 04/10/2003 | WO2002010337A3 Method of cloning porcine animals |
| 04/10/2003 | US20030070185 Animal model for use in the generation of preferential antibodies |
| 04/10/2003 | US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 04/10/2003 | US20030069197 Probes and primers can be employed in diagnostic kits, in identifying or isolating mammalian PTTG nucleic acid, and in detecting a pathological mass associated with PTTG expression. |
| 04/10/2003 | US20030069196 Ameliorating a symptom of an ischemic disorder or injury comprising administering a 200 gene product to ameliorate the symptom of the ischemic disorder or injury. |
| 04/10/2003 | US20030068818 Animal tissue with carbohydrate antigens compatible for human transplantation and a carbohydrate determinant selection system for homologous recombination |
| 04/10/2003 | US20030066491 Apparatus for detecting estrus in livestock |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462628A1 Restricted expression lentiviral vectors |
| 04/10/2003 | CA2462443A1 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | CA2462017A1 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 04/10/2003 | CA2461606A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460257A1 Methods for diagnosing and treating heart disease |
| 04/10/2003 | CA2451685A1 Animal healthcare, well-being and nutrition |
| 04/09/2003 | EP1299546A2 Aminoacyl trna synthetases |
| 04/09/2003 | EP1299540A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 04/09/2003 | EP1298988A2 Transgenic mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on intracellular receptors, and method for the preparation thereof |
| 04/09/2003 | CN1409766A 转基因昆虫 GM insects |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |
| 04/09/2003 | CN1409606A process for enhancing canine and feline reproductive performance |
| 04/09/2003 | CN1409587A Method for forming holes, using flexible connection board formed thereof and its producing method |
| 04/09/2003 | CN1408244A Fodder additive for resisting silkworm microsporidian |
| 04/08/2003 | US6545199 Embryonic germ cells, method for making same, and using the cells to produce a chimeric porcine |
| 04/08/2003 | US6544784 Multiple-tumor aberrant growth genes |
| 04/08/2003 | US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine |
| 04/08/2003 | US6544560 Positioning a plurality of like substrates in sea water, growing the organism on the plurality of substrates, harvesting the grown organism, and extracting the pharmaceutical from the harvested organism |
| 04/03/2003 | WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027277A1 Method of screening reporgramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003027147A2 Human coagulation factor vii polypeptides |
| 04/03/2003 | WO2003026584A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | WO2003026408A1 Model animal with overexpression of regucalcin |
| 04/03/2003 | WO2003026404A2 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto |
| 04/03/2003 | WO2003026399A2 Gng4 gene disruptions, compositions and methods related thereto |
| 04/03/2003 | WO2003026398A2 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto |
| 04/03/2003 | WO2003026396A2 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions |
| 04/03/2003 | WO2003026395A2 Mo54 gene disruptions, compositions and methods related thereto |
| 04/03/2003 | WO2003002722A3 T cell regulatory genes and methods of use thereof |
| 04/03/2003 | WO2002077161A3 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | WO2002059256A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 04/03/2003 | WO2002025270A9 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 04/03/2003 | WO2002010214A3 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/03/2003 | US20030066099 SCCE modified transgenic mammals and their use as models of human disease |
| 04/03/2003 | US20030066097 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease |
| 04/03/2003 | US20030064509 Novel chromosomal vectors and uses thereof |
| 04/03/2003 | US20030064475 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/03/2003 | US20030064074 Recombinant gelatins in vaccines |
| 04/03/2003 | CA2461861A1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 04/03/2003 | CA2461454A1 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461185A1 Method of screening reprogramming factor, reprogramming factor screened by the method, method of using the reprogramming factor, method of differentiating undifferentiated fused cells and method of constructing cell, tissues and organs |
| 04/03/2003 | CA2461003A1 Human coagulation factor vii polypeptides |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2453985A1 Receptors and membrane-associated proteins |
| 04/02/2003 | EP1297745A1 A method of producing avian eggs and birds of specified contamination free status |
| 04/02/2003 | EP1297166A2 Chimeric promoters for controlling expression in smooth muscle cells |
| 04/02/2003 | EP1297152A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 04/02/2003 | EP1297132A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 04/02/2003 | EP1297131A2 Cyk-4 polypeptides, dna molecules encoding them and their use in screening methods |
| 04/02/2003 | EP1297127A2 Gpr22 modulators as appetite-control agents |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | CN1407851A Improved method for production porcine clone embryos via somatic cell nuclear transfer |
| 04/02/2003 | CN1406467A Milk with sensitinogen for treating anaphylaxis |
| 04/02/2003 | CN1406466A Process for propagation of female rana amurensis and inductive feeds therefor |
| 04/01/2003 | US6541681 Mouse with deficiency of gene of neutrophil chemotactic factor LECT2 |
| 04/01/2003 | US6541457 Mammalian IAP gene family, primers, probes and detection methods |
| 04/01/2003 | US6541218 Isolated nucleic acid encoding title protein; genetic engineering; use in diagnosis and treatment of Type B Niemann-Pick Disease |
| 04/01/2003 | US6540996 Compound screening methods |
| 04/01/2003 | CA2102129C Growth hormone antagonists |
| 03/27/2003 | WO2003025220A2 Fusion proteins useful for detecting analytes |
| 03/27/2003 | WO2003025183A2 Random integration of a polynucleotide after in vivo linearization |
| 03/27/2003 | WO2003025163A2 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
| 03/27/2003 | WO2003025159A1 Methods for injecting avian eggs |
| 03/27/2003 | WO2003025146A2 Production of a transgenic avian by cytoplasmic injection |
| 03/27/2003 | WO2003024482A1 Crustaceans as production systems for therapeutic proteins |
| 03/27/2003 | WO2003024206A1 Psammomys obesus as an animal model for behavioural conditions |
| 03/27/2003 | WO2003024200A2 Production of transgenic birds using stage x primordial germ cells |
| 03/27/2003 | WO2002082892A3 Automatic system-based animal training device |
| 03/27/2003 | WO2002077168A3 Mch1r deficient mice |
| 03/27/2003 | WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/27/2003 | WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/27/2003 | WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
| 03/27/2003 | US20030061629 Production of transgenic birds using stage X primordial germ cells |
| 03/27/2003 | US20030061626 Characterisation of gene function using double stranded RNA inhibition |
| 03/27/2003 | US20030059938 Presenilin-deficient multipotent cell lines and screening methods for intramembrane-regulated proteolytic activities using these lines |
| 03/27/2003 | US20030059935 Culture medium for in vitro culture of in vitro-produced porcine embryo and method for in vitro production of procine embryo using the culture medium |
| 03/27/2003 | US20030059922 Sphingosine1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 03/27/2003 | US20030059916 IRAK-4: compositions and methods of use |
| 03/27/2003 | US20030059805 Nucleotide sequences coding polyeptide for use in the treatment of growth disorders in humans |
| 03/27/2003 | US20030059455 A defective recombinant adenovirus including at least one DNA sequence coding for all or an active part of a superoxide; useful for treating and/or preventing Parkinson's disease, Alzheimer's disease, Huntington's disease etc. |
| 03/27/2003 | US20030059445 Free from human or animal elements or proteins and comprises plurality of amino acids in particulate form with a particle size of less than 250 mu m or in lyophilised form |
| 03/27/2003 | US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis |